Neurocrine Biosciences (NASDAQ:NBIX) Upgraded to “Buy” at Zacks Investment Research

According to Zacks, “Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for …

Link to Full Article: Read Here